Vanquish Neo System and Ion Chromatography system

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q000430

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6640

Additional Details
Set Aside

NONE

Place of Performance

-

SourceSAM
Documents4
The U.S. Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a solicitation for the acquisition of two advanced laboratory chromatography systems. This procurement, identified by Solicitation Number 75F40126Q000430, is managed by the FDA Office of Acquisition and Grant Services and is classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing), with Product Service Code 6640. The scope of this solicitation encompasses the supply, delivery, and installation of two distinct chromatography systems, each tailored to the specific needs of separate FDA centers: 1. **Thermo Scientific Vanquish Neo System or Equal**: This system is intended for the FDA Center for Veterinary Medicine (CVM) in Laurel, Maryland. The requirement includes all necessary components and accessories to ensure a complete and functional system, a twelve-month warranty, and two days of on-site liquid chromatography (LC) support. A critical requirement is compatibility with the Government-owned Thermo Fisher Scientific Orbitrap Exploris 240 mass spectrometer and its associated ion-source/interface configuration. 2. **Thermo Scientific Dionex ICS-6000 HPIC System or Equal**: This system is designated for the FDA National Forensic Chemistry Center (NFCC) in Cincinnati, Ohio. The deliverables include all required components, supplies, accessories, installation/start-up services, and on-site analyst familiarization/training to ensure operational readiness. Both systems must meet the technical, performance, and warranty requirements detailed in the solicitation attachments. Offerors are expected to provide itemized pricing for all Contract Line Item Numbers (CLINs) and must clearly identify the manufacturer, make/model, part numbers, country of origin, and place of manufacture for each proposed end product. Comprehensive technical documentation demonstrating compliance with all minimum requirements and salient characteristics is mandatory. The procurement is unrestricted, with no set-aside for small business concerns, and will be awarded using a Lowest Price Technically Acceptable (LPTA) methodology. This approach emphasizes the importance of meeting all technical specifications at the most competitive price. The solicitation remains active, and the closing date for responses is September 21, 2026, at 14:09. The amendment (A00001) clarifies that the question submission period has closed, and no further questions will be addressed. Interested contractors should review Solicitation 75F40126Q000430 and its four attachments for complete requirements, quotation instructions, and applicable terms and conditions. For further information or clarification, the primary point of contact is Iris Johnson, who can be reached at [email protected] or by phone at 301-796-3353. This opportunity is ideal for contractors specializing in analytical laboratory instrument manufacturing and integration, particularly those with experience in chromatography systems compatible with high-end mass spectrometry platforms. The requirements for warranty, technical support, and training underscore the FDA’s commitment to operational excellence and reliability in laboratory instrumentation. For full details and to access the solicitation documents, visit the official notice at [SAM.gov](https://sam.gov/opp/88bce0d89f7948c39aeef0d6ca3581d6/view).